Many Medicaid plans will provide Wegovy coverage for cardiovascular risk reduction, but its best to check with your specific plan to confirm coverage details
While exercising is key to weight loss, maintaining high levels of activity, especially strength training, is essential for long-term weight control, Dr
Multi-indication label expansion: Semaglutide approved across obesity, cardiovascular risk reduction, MASH, and sleep apnea creates a total addressable patient population of approximately 640 million globally nearly four times the obesity-only base adding new prescriber populations including cardiologists, hepatologists, and sleep medicine specialists
semaglutide 2.4 mg as a treatment option for adults with obesity
Over 77% of Microdose GLP-1 Rx Program members stayed engaged with the Noom app for 4 or more weeks, based on an analysis of November 2025 members, and over 40% of December starts returned to the app on day 30